These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 2243960)

  • 1. Complementary roles of PET and MR spectroscopy in the management of brain tumors.
    Alavi A; Alavi JB; Lenkinski RE
    Radiology; 1990 Dec; 177(3):617-8. PubMed ID: 2243960
    [No Abstract]   [Full Text] [Related]  

  • 2. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET.
    Alger JR; Frank JA; Bizzi A; Fulham MJ; DeSouza BX; Duhaney MO; Inscoe SW; Black JL; van Zijl PC; Moonen CT
    Radiology; 1990 Dec; 177(3):633-41. PubMed ID: 2243962
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proceedings of a National Cancer Institute workshop: PET in oncology--a clinical research agenda.
    Wahl RL; Hawkins RA; Larson SM; Hendee WR; Coleman RE; Holden RW; Frick MP; Gatsonis C; Brown GS; Shtern F
    Radiology; 1994 Dec; 193(3):604-6. PubMed ID: 7972793
    [No Abstract]   [Full Text] [Related]  

  • 4. Positron emission tomography of fluorine-18-deoxyglucose and image-guided phosphorus-31 magnetic resonance spectroscopy in brain tumors.
    Heiss WD; Heindel W; Herholz K; Rudolf J; Bunke J; Jeske J; Friedmann G
    J Nucl Med; 1990 Mar; 31(3):302-10. PubMed ID: 2308001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What are the sources of error in measuring and calculating cerebral metabolic rates with fluorine-18-fluorodeoxyglucose and PET?
    Alavi A; Smith R; Duncan D
    J Nucl Med; 1994 Sep; 35(9):1466-70. PubMed ID: 8071693
    [No Abstract]   [Full Text] [Related]  

  • 6. PET, MRI, and epilepsy.
    Arroyo S; Lesser RP
    Neurology; 1993 Oct; 43(10):2156. PubMed ID: 8280264
    [No Abstract]   [Full Text] [Related]  

  • 7. Fluorodeoxyglucose brain metabolism studied by NMR and PET.
    Bolo NR; Brennan KM; Jones RM; Budinger TF
    Ann N Y Acad Sci; 1987; 508():451-9. PubMed ID: 3501936
    [No Abstract]   [Full Text] [Related]  

  • 8. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.
    Schmidt KC; Lucignani G; Sokoloff L
    J Nucl Med; 1996 Feb; 37(2):394-9. PubMed ID: 8667082
    [No Abstract]   [Full Text] [Related]  

  • 9. Inflammatory bowel disease activity measured by positron-emission tomography.
    Bicik I; Bauerfeind P; Breitbach T; von Schulthess GK; Fried M
    Lancet; 1997 Jul; 350(9073):262. PubMed ID: 9242806
    [No Abstract]   [Full Text] [Related]  

  • 10. Clarification of a fractional uptake concept.
    Thie JA
    J Nucl Med; 1995 Apr; 36(4):711-2. PubMed ID: 7699475
    [No Abstract]   [Full Text] [Related]  

  • 11. Simplified calculation of MRglc using PET.
    Phillips RL; London ED
    J Nucl Med; 1997 Aug; 38(8):1334. PubMed ID: 9255178
    [No Abstract]   [Full Text] [Related]  

  • 12. Multimodality correlative study of canine brain tumors. Proton magnetic resonance spectroscopy, positron emission tomography, and histology.
    Anderson JH; Strandberg JD; Wong DF; Conti PS; Barker PB; Blackband SJ; Hilton J; Natarajan TK; Dannals RF; Samphilipo MA
    Invest Radiol; 1994 Jun; 29(6):597-605. PubMed ID: 8088967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycolysis: link between PET and proton MR spectroscopic studies of the brain.
    Lear JL
    Radiology; 1990 Feb; 174(2):328-30. PubMed ID: 2153309
    [No Abstract]   [Full Text] [Related]  

  • 14. Images in neuroscience. Neuroimaging, I.PET with [18F]fluorodeoxyglucose.
    Tamminga CA
    Am J Psychiatry; 1995 Oct; 152(10):1415. PubMed ID: 7573578
    [No Abstract]   [Full Text] [Related]  

  • 15. PET quantitation: blessing and curse.
    Di Chiro G; Brooks RA
    J Nucl Med; 1988 Sep; 29(9):1603-4. PubMed ID: 3261788
    [No Abstract]   [Full Text] [Related]  

  • 16. Magnetic resonance and fluorine-18 deoxyglucose imaging in the investigation of a spinal cord tumor.
    Alavi A; Kramer E; Wegener W; Alavi J
    J Nucl Med; 1990 Mar; 31(3):360-4. PubMed ID: 2155315
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical application of PET for the evaluation of brain tumors.
    Coleman RE; Hoffman JM; Hanson MW; Sostman HD; Schold SC
    J Nucl Med; 1991 Apr; 32(4):616-22. PubMed ID: 2013802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET cancer evaluations with FDG.
    Hawkins RA; Hoh C; Dahlbom M; Choi Y; Glaspy J; Tse N; Slamon D; Chen B; Messa C; Maddahi J
    J Nucl Med; 1991 Aug; 32(8):1555-8. PubMed ID: 1869978
    [No Abstract]   [Full Text] [Related]  

  • 19. PET with fluorine-18 deoxyglucose for pancreatic disease.
    Klever P; Bares R; Fass J; Büll U; Schumpelick V
    Lancet; 1992 Nov; 340(8828):1158-9. PubMed ID: 1359226
    [No Abstract]   [Full Text] [Related]  

  • 20. [Functional brain study by radionuclide neuroimaging].
    Uemura K
    No To Shinkei; 1990 May; 42(5):425-34. PubMed ID: 2206632
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.